Additionally, CX3CL1 triggered cell proliferation by inducing ErbB receptors through the proteolytic shedding of an ErbB ligand, and these findings support the conclusion that CX3CL1 acts as a positive modifier of breast cancer in concert with ErbB receptors (22). The gene discussed is EGFR; the disease is breast carcinoma.